Optimizing antimicrobial prescribing

Boucher, 2009, Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America, Clin Infect Dis, 48, 1, 10.1086/595011 Melzer, 2003, Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia, Clin Infect Dis, 37, 1453, 10.1086/379321 DiazGranados, 2005, Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis, Clin Infect Dis, 41, 327, 10.1086/430909 Tumbarello, 2006, Bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome, Antimicrob Agents Chemother, 50, 498, 10.1128/AAC.50.2.498-504.2006 Kwon, 2007, Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia, J Antimicrob Chemother, 59, 525, 10.1093/jac/dkl499 Aloush, 2006, Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact, Antimicrob Agents Chemother, 50, 43, 10.1128/AAC.50.1.43-48.2006 Marchaim, 2008, Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes, Antimicrob Agents Chemother, 52, 1413, 10.1128/AAC.01103-07 Kollef, 1999, Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients, Chest, 115, 462, 10.1378/chest.115.2.462 Dellit, 2007, Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clin Infect Dis, 44, 159, 10.1086/510393 Lawrence, 2009, Antimicrobial stewardship in the intensive care unit: advances and obstacles, Am J Respir Crit Care Med, 179, 434, 10.1164/rccm.200809-1394CP Cooke, 2007, The missing care bundle: antibiotic prescribing in hospitals, Int J Antimicrob Agents, 30, 25, 10.1016/j.ijantimicag.2007.03.003 Paterson, 2006, The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals, Clin Infect Dis, 42, S90, 10.1086/499407 Paul, 2006, Beta-lactam antibiotic monotherapy versus beta-lactam–aminoglycoside antibiotic combination therapy for sepsis, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD003344.pub2 Paul, 2004, Beta-lactam monotherapy versus beta-lactam–aminoglycoside combination therapy for sepsis in immuno-competent patients: systematic review and meta-analysis of randomised trials, BMJ, 328, 668, 10.1136/bmj.38028.520995.63 Falagas, 2006, The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials, J Antimicrob Chemother, 57, 639, 10.1093/jac/dkl044 Cosgrove, 2009, Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic, Clin Infect Dis, 48, 713, 10.1086/597031 Raveh, 2003, Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990–2000), J Hosp Infect, 55, 196, 10.1016/S0195-6701(03)00286-X Bliziotis, 2005, Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials, Clin Infect Dis, 41, 149, 10.1086/430912 Hegreness, 2008, Accelerated evolution of resistance in multidrug environments, Proc Natl Acad SciUSA, 105, 13977, 10.1073/pnas.0805965105 Ben-Ami, 2009, A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients, Clin Infect Dis, 49, 682, 10.1086/604713 Schechner, 2009, Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?, Clin Infect Dis, 48, 580, 10.1086/596709 Robicsek, 2008, Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling, J Clin Microbiol, 46, 588, 10.1128/JCM.01746-07 Pulcini, 2008, Design of a ‘day 3 bundle’ to improve the reassessment of inpatient empirical antibiotic prescriptions, J Antimicrob Chemother, 61, 1384, 10.1093/jac/dkn113 Cockerill, 1997, Clinical comparison of BACTEC 9240 Plus Aerobic/F resin bottles and the isolator aerobic culture system for detection of bloodstream infections, J Clin Microbiol, 35, 1469, 10.1128/JCM.35.6.1469-1472.1997 Durmaz, 2003, Optimum detection times for bacteria and yeast species with the BACTEC 9120 aerobic blood culture system: evaluation for a 5-year period in a Turkish university hospital, J Clin Microbiol, 41, 819, 10.1128/JCM.41.2.819-821.2003 Rybak, 2006, Pharmacodynamics: relation to antimicrobial resistance, Am J Med, 119, S37, 10.1016/j.amjmed.2006.04.001 Roberts, 2009, Pharmacokinetic issues for antibiotics in the critically ill patient, Crit Care Med, 37, 840, 10.1097/CCM.0b013e3181961bff Chastre, 2003, Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial, JAMA, 290, 2588, 10.1001/jama.290.19.2588 Siegel, 2006 Buising, 2008, Electronic antibiotic stewardship: reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting, J Antimicrob Chemother, 62, 608, 10.1093/jac/dkn218 Buising, 2008, Improving antibiotic prescribing for adults with community-acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone? A time-series analysis, BMC Med Inform Decis Mak, 8, 35, 10.1186/1472-6947-8-35 Eggimann, 2001, Infection control in the ICU, Chest, 120, 2059, 10.1378/chest.120.6.2059 Pakyz, 2008, Trends in antibacterial use in US academic health centers: 2002 to 2006, Arch Int Med, 168, 2254, 10.1001/archinte.168.20.2254 Pope, 2009, Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Infect Control Hosp Epidemiol, 30, 97, 10.1086/592979 Bruce, 2009, Antibiotic stewardship and consumption: findings from a pan-European hospital study, J Antimicrob Chemother, 64, 853, 10.1093/jac/dkp268 Solomon, 2001, Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center, Arch Intern Med, 161, 1897, 10.1001/archinte.161.15.1897 Fraser, 1997, Antibiotic optimization. An evaluation of patient safety and economic outcomes, Arch Int Med, 157, 1689, 10.1001/archinte.1997.00440360105012 Brown, 2005, Antibiotic cycling or rotation: a systematic review of the evidence of efficacy, J Antimicrob Chemother, 55, 6, 10.1093/jac/dkh482 Fridkin, 2003, Routine cycling of antimicrobial agents as an infection-control measure, Clin Infect Dis, 36, 1438, 10.1086/375082 Bergstrom, 2004, Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals, Proc Natl Acad Sci USA, 101, 13285, 10.1073/pnas.0402298101 Bonhoeffer, 1997, Evaluating treatment protocols to prevent antibiotic resistance, Proc Natl Acad SciUSA, 94, 12106, 10.1073/pnas.94.22.12106 Bonten, 2001, Understanding the spread of antibiotic-resistant pathogens in hospitals: mathematical models as tools for control, Clin Infect Dis, 33, 1739, 10.1086/323761 Sandiumenge, 2006, Impact of diversity of antibiotic use on the development of antimicrobial resistance, J Antimicrob Chemother, 57, 1197, 10.1093/jac/dkl097